[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362504-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362504-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mesenchymal-stem-cell-exosome-mediated-delivery-of-paclitaxel-for-pancreatic-cancer-therapy","Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy","","Pancreatic ductal adenocarcinoma (PDAC) remains highly aggressive, and paclitaxel (PTX) is limited by poor solubility, low bioavailability, and systemic toxicity. This study develops mesenchymal stem cell (MSC)-derived exosomes as biocompatible tumor-homing nanocarriers for PTX delivery. Exosomes are isolated by ultracentrifugation and tangential flow filtration (TFF), with TFF improving recovery 8–9-fold. Characterization includes flow cytometry markers (CD63, CD81, CD90), TEM/ DLS size (~160 nm), and zeta potential (~−28 mV). PTX loading via ultrasonication yields 31.3 ± 2.0% encapsulation and shows burst release within 24 h followed by sustained release over 7 days. Blank exosomes show no cytotoxicity, while PTX-loaded exosomes improve antitumor effects versus free PTX, reducing IC50 values and suppressing colony formation and spheroid growth in vitro.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mesenchymal-stem-cell-exosome-mediated-delivery-of-paclitaxel-for-pancreatic-cancer-therapy/362504/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mesenchymal-stem-cell-exosome-mediated-delivery-of-paclitaxel-for-pancreatic-cancer-therapy/362504.png","ImageObject",300,407,{"name":42,"@type":43},"Kyle","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is paclitaxel (PTX) difficult to use for pancreatic ductal adenocarcinoma (PDAC) treatment?","Question",{"text":63,"@type":64},"PTX has poor solubility and low bioavailability, and it can cause systemic toxicity, limiting conventional chemotherapy effectiveness.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were MSC-derived exosomes prepared and characterized in this study?",{"text":68,"@type":64},"Exosomes were isolated from MSC-conditioned media using ultracentrifugation and tangential flow filtration (TFF). Flow cytometry confirmed exosomal and MSC markers (CD63, CD81, CD90), while TEM and dynamic light scattering showed spherical vesicles (~160 nm) with a zeta potential near −28 mV.",{"name":70,"@type":61,"acceptedAnswer":71},"What effect did PTX-loaded exosomes have compared with free PTX?",{"text":72,"@type":64},"PTX-loaded exosomes significantly increased cytotoxicity, lowering IC50 values and more effectively suppressing colony formation and spheroid growth in PDAC cell models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362504,1790691437,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":104,"preview_page_count":33,"preview_urls":145},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Article  \nMesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy  \nAnurag Banerjee 1, Arpita Ghosal 1, Paras Mani Giri 1, Sakurako Tani 2, Yongki Choi 2 and Buddhadev Layek 1, *  \nAcademic Editors: Amalendu P. Ranjan, Nirupama A. Sabnis and Zacharias Suntres  \nReceived: 24 December 2025  \nRevised: 2 February 2026  \nAccepted: 5 February 2026  \nPublished: 9 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58105, USA;  \n[anurag.banerjee@ndsu.edu](anurag.banerjee@ndsu.edu) (A.B.); [arpita.ghosal@ndsu.edu](arpita.ghosal@ndsu.edu) (A.G.); [paras.giri@ndsu.edu](paras.giri@ndsu.edu) (P.M.G.)  \n2 Department of Physics, North Dakota State University, Fargo, ND 58102, USA; [sakurako.tani@ndsu.edu](sakurako.tani@ndsu.edu) (S.T.); [yongki.choi@ndsu.edu](yongki.choi@ndsu.edu) (Y.C.)  \n* [Correspondence: buddhadev.layek@ndsu.edu](Correspondence: buddhadev.layek@ndsu.edu)  \nAbstract  \nPancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies, with limited response to conventional chemotherapies such as paclitaxel (PTX) due to poor solubility, low bioavailability, and systemic toxicity. To address these limitations, this study explores mesenchymal stem cell (MSC)-derived exosomes as biocompatible, tumorhoming nanocarriers for PTX delivery. Exosomes were isolated from MSC-conditioned media using ultracentrifugation and tangential flow filtration (TFF), with TFF yielding 8 to 9-fold higher exosome recovery. Flow cytometry confirmed the presence of exosomal (CD63, CD81) and MSC (CD90) surface markers, while transmission electron microscopy and dynamic light scattering revealed spherical vesicles averaging ~160 nm in diameter with a zeta potential of approximately −28 mV. PTX was loaded into exosomes using ultrasonication, achieving an encapsulation efficiency of 31.3 ± 2.0%, and release studies showed an initial burst within 24 h followed by sustained release over 7 days. Blank exosomes exhibited no cytotoxicity toward PANC-1, BxPC-3, and HPNE cells, confirming their excellent biocompatibility. In contrast, PTX-loaded exosomes significantly enhanced cytotoxicity compared to free PTX, reducing IC 50 values from 12.48 nM to 7.55 nM in BxPC-3 cells and from 22.44 nM to 19.29 nM in PANC-1 cells and suppressed colony formation and spheroid growth more effectively. These findings demonstrate that MSC-derived exosomes can efficiently encapsulate and deliver PTX, enhancing its antitumor efficacy. This exosome-based platform offers a promising strategy to overcome pharmacological barriers and improve therapeutic outcomes in PDAC.  \nKeywords: mesenchymal stem cell-derived exosomes; nanomedicine; paclitaxel; pancreatic ductal adenocarcinoma; 3D spheroid model  \n1. Introduction  \nPancreatic cancer is one of the most lethal solid tumors, accounting for approximately 8% of cancer-related deaths in the United States, despite representing only about 3% of all cancer cases [1] . The five-year survival rate is approximately 13%, the lowest among major cancers. This dismal prognosis is primarily due to late detection, as early-stage pancreatic cancer typically lacks specific symptoms and reliable diagnostic markers [2] . Consequently, most cases are identified at advanced or metastatic stages, with only about 15% of patients eligible for surgical intervention, so most rely on chemotherapy [3] . The standard first-line treatments of pancreatic cancer include gemcitabine, alone or with  \nother drugs like Abraxane (albumin-bound paclitaxel) or FOLFIRINOX (a regimen offolinic acid, 5-fluorouracil, irinotecan, and oxaliplatin) [4] . However, the therapeutic efficacy of conventional chemotherapeutics is often limited by poor tumor selectivity [5,6], sever","cbCairAicvY4GdGK","https://ap.wps.com/l/cbCairAicvY4GdGK","pdf",5801798,"English","# Abstract\n# 1. Introduction\n## Challenges in pancreatic cancer chemotherapy\n## Nanocarrier approaches and remaining barriers\n## Exosomes as targeted nanovesicles and MSC-derived potential","[{\"question\":\"Why is paclitaxel (PTX) difficult to use for pancreatic ductal adenocarcinoma (PDAC) treatment?\",\"answer\":\"PTX has poor solubility and low bioavailability, and it can cause systemic toxicity, limiting conventional chemotherapy effectiveness.\"},{\"question\":\"How were MSC-derived exosomes prepared and characterized in this study?\",\"answer\":\"Exosomes were isolated from MSC-conditioned media using ultracentrifugation and tangential flow filtration (TFF). Flow cytometry confirmed exosomal and MSC markers (CD63, CD81, CD90), while TEM and dynamic light scattering showed spherical vesicles (~160 nm) with a zeta potential near −28 mV.\"},{\"question\":\"What effect did PTX-loaded exosomes have compared with free PTX?\",\"answer\":\"PTX-loaded exosomes significantly increased cytotoxicity, lowering IC50 values and more effectively suppressing colony formation and spheroid growth in PDAC cell models.\"}]","Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy | PDF",1790148010,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d6d215db7b9d2a57784398b6f3c62ae.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f768015ea423c6325bf9b1a5e8f15425.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77d2a81452f0ccc00da663b17768f26c.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b32452cd48372c0557534370fbca0855.webp",980,1385]